Amneal (AMRX) Director J. Kevin Buchi Gifts 20,445 Shares

What Happened J. Kevin Buchi, a director of Amneal Pharmaceuticals (AMRX), transferred (gifted) 20,445 shares of Class A common stock on September 17, 2026. The reported transaction price was $0.00 and the total proceeds were $0. According to the filing footnote, the shares were moved into a trust to which Buchi is the trustee.

Key Details

• Transaction date: 2026-09-17; Filing date (Form 4): 2026-09-21 (filed within the two-business-day SEC deadline).
• Transaction type/code: Gift (G); price per share reported as $0.00; total value $0.
• Shares transferred: 20,445 shares of Class A common stock.
• Shares owned after transaction: not specified in the provided summary of the filing.
• Footnote: The reporting person transferred the shares to a trust for no consideration and is the trustee of that trust.

Context Gifts or transfers to trusts are common estate-planning or family-planning moves and do not necessarily signal the insider’s view on the company’s prospects. This was not a sale or purchase and generated no proceeds for the reporting person.